The annuloplasty system market size has grown strongly in recent years. It will grow from $0.7 billion in 2025 to $0.75 billion in 2026 at a compound annual growth rate (CAGR) of 7%. The growth in the historic period can be attributed to increasing prevalence of valvular heart diseases, expansion of cardiac surgery programs, adoption of surgical valve repair over replacement, advancements in biomaterials for implants, improved surgical training and techniques.
The annuloplasty system market size is expected to see strong growth in the next few years. It will grow to $0.97 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to increasing demand for minimally invasive cardiac procedures, rising aging population with valve disorders, growing adoption of robotic cardiac surgery, expansion of transcatheter treatment options, continuous innovation in annuloplasty device design. Major trends in the forecast period include increasing adoption of minimally invasive valve repair techniques, growing use of robotic-assisted annuloplasty procedures, rising preference for flexible and adjustable annuloplasty devices, expansion of transcatheter annuloplasty systems, enhanced focus on long-term valve durability.
The rising prevalence of cardiovascular diseases is expected to drive the growth of the annuloplasty system market in the coming years. Cardiovascular diseases encompass a group of disorders affecting the heart and blood vessels, including coronary heart disease, heart failure, stroke, and hypertension. The increasing prevalence of these conditions is largely attributed to the aging population, as age-related wear and tear on the heart and blood vessels elevates the risk of heart disease. Annuloplasty systems support cardiovascular treatment by providing effective solutions for heart valve repair, restoring proper valve function, and improving blood flow. They enhance patient outcomes by offering minimally invasive options for valve restoration, reducing both recovery time and surgical risks. For example, in September 2023, the World Health Organization, a Switzerland-based specialized agency of the United Nations, reported that globally there were 41 million deaths annually, representing 74% of deaths caused by non-communicable or chronic diseases. Among these, 17.9 million deaths were due to cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2 million from diabetes. Consequently, the rising prevalence of cardiovascular diseases is fueling the growth of the annuloplasty system market.
Leading companies in the annuloplasty system market are focusing on developing innovative products such as next-generation surgical valves and devices to improve procedural efficiency and long-term patient outcomes. These next-generation surgical valves and devices are advanced medical technologies designed to simplify implantation, reduce surgical complexity, and enhance the precision and durability of valve repairs or replacements. For instance, in June 2024, Medtronic plc, a US-based medical technology firm, introduced the Avalus Ultra valve, a next-generation surgical aortic tissue valve. This device facilitates easier implantation with its low-profile valve holder and durable polyetheretherketone (PEEK) base frame, improving surgical ease and long-term functionality. It also enhances blood flow dynamics and offers visibility for future valve-in-valve procedures.
In July 2024, Affluent Medical SAS, a medical device company based in France, acquired Edwards Lifesciences Corporation for $16.3 million. This acquisition aims to expand Affluent Medical’s presence in the cardiovascular market by strengthening its portfolio of heart valve solutions. It aligns with the company’s strategic goal to accelerate the development of advanced therapies for heart disease and improve patient outcomes. Edwards Lifesciences is a US-based medical technology company specializing in annuloplasty systems for mitral and tricuspid valve repair to support heart valve restoration.
Major companies operating in the annuloplasty system market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Edwards Lifesciences Corporation, LivaNova PLC, MicroPort Scientific Corporation, Terumo Corporation, B. Braun Melsungen AG, B. Braile Biomedica, Affluent Medical, Micro Interventional Devices Inc., NeoChord Inc., BioVentrix Inc., CryoLife Inc., Genesse BioMedical, BioStable Science & Engineering Inc., FOC Medical S.A., Cardiac Implants LLC, Medtentia International Ltd., Corcym S.r.l.
North America was the largest region in the annuloplasty system market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the annuloplasty system market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the annuloplasty system market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the annuloplasty system market by increasing costs of imported biomaterials, precision metal components, surgical-grade polymers, and robotic-assisted device parts used in annuloplasty rings and suture systems. Cardiac care providers in North America and Europe are most affected due to reliance on imported specialized devices, while Asia-Pacific faces cost pressures on device manufacturing and distribution. These tariffs are increasing procedural costs and procurement budgets for hospitals. At the same time, they are supporting local manufacturing, regional supplier development, and increased investment in domestic cardiovascular device production.
The annuloplasty system market research report is one of a series of new reports that provides annuloplasty system market statistics, including annuloplasty system industry global market size, regional shares, competitors with a annuloplasty system market share, detailed annuloplasty system market segments, market trends and opportunities, and any further data you may need to thrive in the annuloplasty system industry. This annuloplasty system market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
An annuloplasty system is a medical device utilized in heart valve repair surgeries, primarily to treat valve dysfunction. It consists of a ring or band that is placed around the heart valve annulus to reshape or strengthen it, ensuring the valve closes properly. This device helps restore normal valve function and prevents the backward flow of blood within the heart, thereby enhancing heart performance and patient outcomes.
The main types of annuloplasty systems include annular rings and bands, as well as suture annuloplasty devices. Annular rings and bands are implantable devices used in heart valve repair surgeries, especially during annuloplasty procedures. These procedures may be performed via open-heart surgery, minimally invasive techniques, or robot-assisted methods. Annuloplasty systems are applied to various heart valves, including the mitral, tricuspid, aortic, and pulmonary valves, serving end users such as hospitals, ambulatory surgical centers, and cardiac care facilities.
The annuloplasty system market consists of sales of flexible annuloplasty rings, rigid annuloplasty rings, semi-rigid rings, adjustable bands, surgical tools, implantable devices, and associated accessories used in heart valve repair procedures. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The annuloplasty system market size is expected to see strong growth in the next few years. It will grow to $0.97 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to increasing demand for minimally invasive cardiac procedures, rising aging population with valve disorders, growing adoption of robotic cardiac surgery, expansion of transcatheter treatment options, continuous innovation in annuloplasty device design. Major trends in the forecast period include increasing adoption of minimally invasive valve repair techniques, growing use of robotic-assisted annuloplasty procedures, rising preference for flexible and adjustable annuloplasty devices, expansion of transcatheter annuloplasty systems, enhanced focus on long-term valve durability.
The rising prevalence of cardiovascular diseases is expected to drive the growth of the annuloplasty system market in the coming years. Cardiovascular diseases encompass a group of disorders affecting the heart and blood vessels, including coronary heart disease, heart failure, stroke, and hypertension. The increasing prevalence of these conditions is largely attributed to the aging population, as age-related wear and tear on the heart and blood vessels elevates the risk of heart disease. Annuloplasty systems support cardiovascular treatment by providing effective solutions for heart valve repair, restoring proper valve function, and improving blood flow. They enhance patient outcomes by offering minimally invasive options for valve restoration, reducing both recovery time and surgical risks. For example, in September 2023, the World Health Organization, a Switzerland-based specialized agency of the United Nations, reported that globally there were 41 million deaths annually, representing 74% of deaths caused by non-communicable or chronic diseases. Among these, 17.9 million deaths were due to cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2 million from diabetes. Consequently, the rising prevalence of cardiovascular diseases is fueling the growth of the annuloplasty system market.
Leading companies in the annuloplasty system market are focusing on developing innovative products such as next-generation surgical valves and devices to improve procedural efficiency and long-term patient outcomes. These next-generation surgical valves and devices are advanced medical technologies designed to simplify implantation, reduce surgical complexity, and enhance the precision and durability of valve repairs or replacements. For instance, in June 2024, Medtronic plc, a US-based medical technology firm, introduced the Avalus Ultra valve, a next-generation surgical aortic tissue valve. This device facilitates easier implantation with its low-profile valve holder and durable polyetheretherketone (PEEK) base frame, improving surgical ease and long-term functionality. It also enhances blood flow dynamics and offers visibility for future valve-in-valve procedures.
In July 2024, Affluent Medical SAS, a medical device company based in France, acquired Edwards Lifesciences Corporation for $16.3 million. This acquisition aims to expand Affluent Medical’s presence in the cardiovascular market by strengthening its portfolio of heart valve solutions. It aligns with the company’s strategic goal to accelerate the development of advanced therapies for heart disease and improve patient outcomes. Edwards Lifesciences is a US-based medical technology company specializing in annuloplasty systems for mitral and tricuspid valve repair to support heart valve restoration.
Major companies operating in the annuloplasty system market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Edwards Lifesciences Corporation, LivaNova PLC, MicroPort Scientific Corporation, Terumo Corporation, B. Braun Melsungen AG, B. Braile Biomedica, Affluent Medical, Micro Interventional Devices Inc., NeoChord Inc., BioVentrix Inc., CryoLife Inc., Genesse BioMedical, BioStable Science & Engineering Inc., FOC Medical S.A., Cardiac Implants LLC, Medtentia International Ltd., Corcym S.r.l.
North America was the largest region in the annuloplasty system market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the annuloplasty system market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the annuloplasty system market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the annuloplasty system market by increasing costs of imported biomaterials, precision metal components, surgical-grade polymers, and robotic-assisted device parts used in annuloplasty rings and suture systems. Cardiac care providers in North America and Europe are most affected due to reliance on imported specialized devices, while Asia-Pacific faces cost pressures on device manufacturing and distribution. These tariffs are increasing procedural costs and procurement budgets for hospitals. At the same time, they are supporting local manufacturing, regional supplier development, and increased investment in domestic cardiovascular device production.
The annuloplasty system market research report is one of a series of new reports that provides annuloplasty system market statistics, including annuloplasty system industry global market size, regional shares, competitors with a annuloplasty system market share, detailed annuloplasty system market segments, market trends and opportunities, and any further data you may need to thrive in the annuloplasty system industry. This annuloplasty system market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
An annuloplasty system is a medical device utilized in heart valve repair surgeries, primarily to treat valve dysfunction. It consists of a ring or band that is placed around the heart valve annulus to reshape or strengthen it, ensuring the valve closes properly. This device helps restore normal valve function and prevents the backward flow of blood within the heart, thereby enhancing heart performance and patient outcomes.
The main types of annuloplasty systems include annular rings and bands, as well as suture annuloplasty devices. Annular rings and bands are implantable devices used in heart valve repair surgeries, especially during annuloplasty procedures. These procedures may be performed via open-heart surgery, minimally invasive techniques, or robot-assisted methods. Annuloplasty systems are applied to various heart valves, including the mitral, tricuspid, aortic, and pulmonary valves, serving end users such as hospitals, ambulatory surgical centers, and cardiac care facilities.
The annuloplasty system market consists of sales of flexible annuloplasty rings, rigid annuloplasty rings, semi-rigid rings, adjustable bands, surgical tools, implantable devices, and associated accessories used in heart valve repair procedures. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Annuloplasty System Market Characteristics
3. Annuloplasty System Market Supply Chain Analysis
4. Global Annuloplasty System Market Trends and Strategies
5. Annuloplasty System Market Analysis of End Use Industries
7. Global Annuloplasty System Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Annuloplasty System Total Addressable Market (TAM) Analysis for the Market
9. Annuloplasty System Market Segmentation
10. Annuloplasty System Market Regional and Country Analysis
11. Asia-Pacific Annuloplasty System Market
12. China Annuloplasty System Market
13. India Annuloplasty System Market
14. Japan Annuloplasty System Market
15. Australia Annuloplasty System Market
16. Indonesia Annuloplasty System Market
17. South Korea Annuloplasty System Market
18. Taiwan Annuloplasty System Market
19. South East Asia Annuloplasty System Market
20. Western Europe Annuloplasty System Market
21. UK Annuloplasty System Market
22. Germany Annuloplasty System Market
23. France Annuloplasty System Market
24. Italy Annuloplasty System Market
25. Spain Annuloplasty System Market
26. Eastern Europe Annuloplasty System Market
27. Russia Annuloplasty System Market
28. North America Annuloplasty System Market
29. USA Annuloplasty System Market
30. Canada Annuloplasty System Market
31. South America Annuloplasty System Market
32. Brazil Annuloplasty System Market
33. Middle East Annuloplasty System Market
34. Africa Annuloplasty System Market
36. Annuloplasty System Market Competitive Landscape and Company Profiles
37. Annuloplasty System Market Other Major and Innovative Companies
40. Annuloplasty System Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Annuloplasty System Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses annuloplasty system market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for annuloplasty system? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The annuloplasty system market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Device Type: Annular Rings And Bands; Suture Annuloplasty Devices2) By Procedure Type: Open Heart Surgery; Minimally Invasive Annuloplasty; Robotic Assisted Annuloplasty
3) By Valve Type: Mitral Valve; Tricuspid Valves; Aortic Valves; Pulmonary Valves
4) By End User: Hospitals; Ambulatory Surgical Centers; Cardiac Care Centers
Subsegments:
1) By Annular Rings And Bands: Rigid Annuloplasty Rings; Semi-Rigid Annuloplasty Rings; Flexible Annuloplasty Rings; Complete Annuloplasty Rings; Incomplete Annuloplasty Rings2) By Suture Annuloplasty Devices: Adjustable Suture Annuloplasty Devices; Non-Adjustable Suture Annuloplasty Devices; Transcatheter Suture Annuloplasty Systems; Robotic-Assisted Suture Annuloplasty Devices
Companies Mentioned: Abbott Laboratories; Medtronic PLC; Boston Scientific Corporation; Edwards Lifesciences Corporation; LivaNova PLC; MicroPort Scientific Corporation; Terumo Corporation; B. Braun Melsungen AG; B. Braile Biomedica; Affluent Medical; Micro Interventional Devices Inc.; NeoChord Inc.; BioVentrix Inc.; CryoLife Inc.; Genesse BioMedical; BioStable Science & Engineering Inc.; FOC Medical S.A.; Cardiac Implants LLC; Medtentia International Ltd.; Corcym S.r.l.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Annuloplasty System market report include:- Abbott Laboratories
- Medtronic PLC
- Boston Scientific Corporation
- Edwards Lifesciences Corporation
- LivaNova PLC
- MicroPort Scientific Corporation
- Terumo Corporation
- B. Braun Melsungen AG
- B. Braile Biomedica
- Affluent Medical
- Micro Interventional Devices Inc.
- NeoChord Inc.
- BioVentrix Inc.
- CryoLife Inc.
- Genesse BioMedical
- BioStable Science & Engineering Inc.
- FOC Medical S.A.
- Cardiac Implants LLC
- Medtentia International Ltd.
- Corcym S.r.l.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 0.75 Billion |
| Forecasted Market Value ( USD | $ 0.97 Billion |
| Compound Annual Growth Rate | 6.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
